相关实验视频
Updated: Jan 17, 2026

09:49
Experimental Model to Evaluate Resolution of Pneumonia
Published on: February 17, 2023
1.8K
急性呼吸阻碍综合征分子表型具有明显的下呼吸道转录组
Aartik Sarma1,2,3, Stephanie A Christenson1, Beth Zha Shoshana1
1Division of Pulmonary, Critical Care, Allergy, and Sleep Medicine.
American journal of respiratory and critical care medicine
|September 25, 2025
概括
急性呼吸窘迫综合征 (ARDS) 有两个不同的分子表型:超炎症和低炎症. 超炎症性ARDS显示出独特的肺生物学,包括干扰素刺激的基因表达和T细胞激活的增加.
科学领域:
- 肺部医学 肺部医学
- 免疫学 免疫学 免疫学
- 基因组学就是基因组学.
背景情况:
- 根据血生物标志物,已经确定了两种急性呼吸窘迫综合征 (ARDS) 的分子表型,即高炎症和低炎症.
- 这些表型表现出不同的临床结果和治疗反应.
- 然而,这些ARDS表型背后的独特肺生物学在很大程度上仍未被探索.
研究的目的:
- 阐明高炎症和低炎症ARDS分子表型之间的肺生物学差异.
- 为了研究气管吸附物和血蛋白质组数据中的基因表达模式.
主要方法:
- 在COVID-19和非COVID-19ARDS队列中使用散装和单细胞RNA测序 (RNASeq) 进行气管吸附基因表达的比较.
- 在一小部分受试者中分析了血蛋白质组数据.
- 利用基因组丰富分析和网络分析来识别差异表达的基因和途径.
主要成果:
- 在COVID-19和非COVID-19队列中,在ARDS表型之间发现了基因表达的显著差异.
- 在高炎症性ARDS中,包括IL32,HSPA8和PPP3CC在内的18个基因被持续上调.
- 在高炎症性ARDS中丰富的途径包括颗粒构造,T细胞信号和综合应激反应,由单细胞RNASeq证实.
结论:
- 独特的呼吸系统生物学特征是高炎症和低炎症的ARDS分子表型.
- 超炎症性ARDS与增加的肺免疫反应有关,特别是干扰素刺激的基因表达和T细胞激活的增加.
相关概念视频
Acute Respiratory Failure-IV
513
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
513
Acute Respiratory Failure-II
1.0K
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.0K
Acute Respiratory Failure-I
855
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
855
Common Respiratory Disorders
1.3K
Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
1.3K
Acute Respiratory Failure-V
462
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
462
Acute Respiratory Failure-III
788
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
788

